1224708-45-5

Basic information

• Product Name: Ethanone, 1-[4-(4-amino-3-methoxyphenyl)-1-piperidinyl]-
• CAS NO: 1224708-45-5
• Molecular Weight: 248.325
• Mol File: 1224708-45-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Ethanone, 1-[4-(4-amino-3-methoxyphenyl)-1-piperidinyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Ethanone, 1-[4-(4-amino-3-methoxyphenyl)-1-piperidinyl]-(1224708-45-5)
• EPA Substance Registry System: Ethanone, 1-[4-(4-amino-3-methoxyphenyl)-1-piperidinyl]-(1224708-45-5)

Safety Data

• Hazardous Substances Data: 1224708-45-5(Hazardous Substances Data)

Usage

General Description

Ethanone, 1-[4-(4-amino-3-methoxyphenyl)-1-piperidinyl]- is a chemical compound that consists of a piperidinyl group attached to a ketone. The compound contains a piperidine ring with an amino group and a methoxy group attached to the 4th position of the phenyl ring. This chemical is often used in pharmaceutical research and drug development, particularly in the study of neurological disorders and pain management. Its structure and properties make it a potential candidate for the development of new medications targeting specific receptors in the central nervous system. Additionally, the compound's piperidinyl group may also contribute to its potential as a bioactive substance in various biological systems.

Upstream product

• 375853-82-0 tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-1(2H)-pyridinecarboxylate 
• 6627-53-8 1-chloro-3-methoxy-4-nitrobenzene 
• 1116228-85-3 4-(3-methoxy-4-nitro-phenyl)-1,2,3,6-tetrahydropyridine 
• 1233145-65-7 4-(3-methoxy-4-nitro-phenyl)-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester 
• 2735-73-1 1,3-diacetyl-1,3-dihydro-benzoimidazol-2-one 

Downstream Products

• 1224703-37-0 5-chloro-4-imidazo[1,2-a]pyridin-3-yl-N-[2-methoxy-4-(4-piperidyl)phenyl]pyrimidin-2-amine 

Relevant articles and documents

Tyrosine Kinase Inhibitor And Uses Thereof

Disclosed is a compound of Formula (I) or a pharmaceutically acceptable salt, ester, or solvate thereof, or their stereoisomers, which can be used as tyrosine kinase inhibitor. Also disclosed is a method for preparing the compound, a pharmaceutical composition and a kit comprising the compound, and uses of the compound. The compound can be used as tyrosine kinase inhibitor, or can be used to reduce or inhibit activity of EGFR or mutant thereof, such as EGFR mutant comprising T790M mutation, in a cell, or to treat and/or prevent a disease associated with overactivity of EGFR, such as cancer.

NOVEL COMPOUNDS 515

There is provided novel pyrimidine derivatives of formula (I) or pharmaceutically acceptable salts thereof, processes for their preparation, pharmaceutical compositions containing them and their use in therapy